Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other



Keyes Jason A Create: Alert

All | News | Filings
Date FiledTypeDescription
02/07/2023 4 Keyes Jason A (CFO) has filed a Form 4 on Equillium, Inc.
Txns: Granted 125,000 options to buy @ $3.86, valued at $482.5k
01/04/2023 4 Keyes Jason A (CFO) has filed a Form 4 on Equillium, Inc.
Txns: Granted 4,444 shares @ $1.19, valued at $5.3k
Granted 175,000 options to buy @ $1.06, valued at $185.5k
08/30/2022 4 Keyes Jason A (CFO) has filed a Form 4 on Equillium, Inc.
Txns: Sold 7,000 shares @ $2.83, valued at $19.8k
06/24/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/06/2022 4 Keyes Jason A (CFO) has filed a Form 4 on Equillium, Inc.
Txns: Sold 5,000 shares @ $2.52, valued at $12.6k
04/05/2022 4 Keyes Jason A (CFO) has filed a Form 4 on Equillium, Inc.
Txns: Sold 8,000 shares @ $3.18, valued at $25.4k
12/13/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
12/03/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
09/29/2021 4 Keyes Jason A (CFO) has filed a Form 4 on Equillium, Inc.
Txns: Sold 8,000 shares @ $6.7405, valued at $53.9k
07/28/2021 4 Keyes Jason A (CFO) has filed a Form 4 on Equillium, Inc.
Txns: Sold 5,000 shares @ $5.717, valued at $28.6k
06/14/2021 4 Keyes Jason A (CFO) has filed a Form 4 on Equillium, Inc.
Txns: Granted 5,535 shares @ $2.35, valued at $13k
05/28/2021 4/A Keyes Jason A (CFO) has filed a Form 4 on Equillium, Inc.
Txns: Sold 5,000 shares @ $6.4967, valued at $32.5k
05/28/2021 4 Keyes Jason A (CFO) has filed a Form 4 on Equillium, Inc.
Txns: Sold 5,000 shares @ $6.4967, valued at $32.5k
05/05/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/06/2021 4 Keyes Jason A (CFO) has filed a Form 4 on Equillium, Inc.
Txns: Granted 100,000 options to buy @ $5.03, valued at $503k
12/28/2020 4 Keyes Jason A (CFO) has filed a Form 4 on Equillium, Inc.
Txns: Sold 8,000 shares @ $4.7392, valued at $37.9k
12/11/2020 4 Keyes Jason A (CFO) has filed a Form 4 on Equillium, Inc.
Txns: Acquired 5,362 shares @ $2.35, valued at $12.6k
06/12/2020 4 Keyes Jason A (CFO) has filed a Form 4 on Equillium, Inc.
Txns: Acquired 5,014 shares @ $2.41, valued at $12.1k
05/08/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
04/24/2020 4 Keyes Jason A (CFO) has filed a Form 4 on Equillium, Inc.
Txns: Disposed/sold 70,000 options to buy @ $7.16, valued at $501.2k
Granted 70,000 options to buy @ $2.45, valued at $171.5k
Disposed/sold 90,000 options to buy @ $4.75, valued at $427.5k
Granted 90,000 options to buy @ $2.45, valued at $220.5k
02/26/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/26/2020 3 Form 3 - Initial statement of beneficial ownership of securities:
02/19/2020 4 Keyes Jason A (CFO) has filed a Form 4 on Equillium, Inc.
Txns: Sold 5,000 shares @ $5.0275, valued at $25.1k
01/22/2020 4 Keyes Jason A (CFO) has filed a Form 4 on Equillium, Inc.
Txns: Sold 5,000 shares @ $4.4086, valued at $22k
12/12/2019 4 Keyes Jason A (CFO) has filed a Form 4 on Equillium, Inc.
Txns: Granted 90,000 options to buy @ $4.75, valued at $427.5k
09/04/2019 4 Keyes Jason A (CFO) has filed a Form 4 on Equillium, Inc.
Txns: Sold 5,000 shares @ $3.5961, valued at $18k
08/05/2019 4 Keyes Jason A (CFO) has filed a Form 4 on Equillium, Inc.
Txns: Sold 5,000 shares @ $3.9882, valued at $19.9k
02/15/2019 4 Keyes Jason A (CFO) has filed a Form 4 on Equillium, Inc.
Txns: Granted 70,000 options to buy @ $7.16, valued at $501.2k
10/11/2018 3 Form 3 - Initial statement of beneficial ownership of securities:
10/17/2017 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/07/2017 4 Form 4 - Statement of changes in beneficial ownership of securities
12/02/2016 4 Form 4 - Statement of changes in beneficial ownership of securities
07/14/2016 4 Keyes Jason A (SVP, CFO) has filed a Form 4 on Orexigen Therapeutics, Inc.
Txns: Granted 131,250 options @ $4.02, valued at $527.6k
Granted 26,250 options @ $4.02, valued at $105.5k
Granted 78,750 options @ $15, valued at $1.2M
Granted 15,750 options @ $15, valued at $236.3k
07/01/2016 3 Keyes Jason A (SVP, CFO) has filed a Form 3 on Orexigen Therapeutics, Inc.

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy